EP.08F.14 Outcomes of Durvalumab Consolidation Treatment in Stage III Unresectable NSCLC: A Retrospective Real-World Study

Autor: Ljubicic, L., Bitar, L., Seiwerth, F., Bacelic-Gabelica, A., Srdic, D., Badovinac, S., Plestina, S., Korsic, M., Pavic, T., Samarzija, M., Jakopovic, M.
Zdroj: In Journal of Thoracic Oncology October 2024 19(10) Supplement:S586-S586
Databáze: ScienceDirect